Anzeige
Mehr »
Login
Samstag, 27.04.2024 Börsentäglich über 12.000 News von 686 internationalen Medien
Nurexone Biologic: Jetzt diese wirklich einzigartige Chance ergreifen?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A0MV6A | ISIN: US7476191041 | Ticker-Symbol: 4Q2
Frankfurt
26.04.24
08:02 Uhr
31,400 Euro
+0,200
+0,64 %
1-Jahres-Chart
QUANEX BUILDING PRODUCTS CORPORATION Chart 1 Jahr
5-Tage-Chart
QUANEX BUILDING PRODUCTS CORPORATION 5-Tage-Chart
RealtimeGeldBriefZeit
31,00032,20011:22
GlobeNewswire (Europe)
379 Leser
Artikel bewerten:
(2)

Quanex Building Products Corporation: Quanex Building Products Announces First Quarter 2024 Results and Provides Full Year 2024 Guidance

Margin Expansion on a Consolidated Basis
Repaid $5 Million in Bank Debt
Balance Sheet and Liquidity Remain Strong
Cautiously Optimistic on Second Half of 2024
Positive Long-Term View on Residential Housing Market Remains Intact

HOUSTON, March 07, 2024 (GLOBE NEWSWIRE) --Quanex Building Products Corporation (NYSE:NX) ("Quanex" or the "Company") today announced its results for the three months ended January 31, 2024.

The Company reported the following selected financial results:

Three Months Ended January 31,
($ in millions, except per share data) 2024 2023
Net Sales $239.2 $261.9
Gross Margin $51.4 $51.8
Gross Margin % 21.5% 19.8%
Net Income $6.2 $1.9
Diluted EPS $0.19 $0.06
Adjusted Net Income $5.8 $6.1
Adjusted Diluted EPS $0.18 $0.18
Adjusted EBITDA $19.3 $20.5
Adjusted EBITDA Margin % 8.1% 7.8%
Cash Provided by Operating Activities $3.9 $3.1
Free Cash Flow ($5.7) ($4.4)

(See Non-GAAP Terminology Definitions and Disclaimers section, Non-GAAP Financial Measure Disclosure table, Selected Segment Data table and reconciliation tables for additional information)

George Wilson, President and Chief Executive Officer, stated, "We were able to realize margin expansion on a consolidated basis for the first quarter of 2024 despite market volume softness related to normal seasonality combined with ongoing macroeconomic challenges, and some pricing pressure. Our focus on generating cash and managing working capital enabled us to pay down our bank debt by $5 million during the quarter, which is encouraging considering we have historically been a net borrower during the first quarter of our fiscal year due to the seasonality of our business. Our balance sheet remains strong, and we continue to be positioned well to explore and evaluate both organic and inorganic growth opportunities."

First Quarter 2024 Results Summary

Quanex reported net sales of $239.2 million during the three months ended January 31, 2024, which represents a decrease of 8.7% compared to $261.9 million for the same period of 2023. The decrease was largely attributable to softer market demand and lower pricing in North America. Quanex reported a 3.3% decline in net sales for the first quarter of 2024 in its North American Fenestration segment. In its North American Cabinet Components segment, Quanex reported a decline of 21.1% in net sales for the first quarter. Excluding foreign exchange impact, the Company realized a decrease in net sales of 8.4% for the first quarter in its European Fenestration segment. (See Sales Analysis table for additional information)

The increase in earnings for the three months ended January 31, 2024 was mostly attributable to a decline in raw material costs, a decrease in stock-based compensation expense and lower interest expense.

Balance Sheet Update

As of January 31, 2024, Quanex had total debt of $65.2 million ($13.5 million excluding real-estate leases that are considered "finance" leases under U.S. GAAP) and the Company's leverage ratio of Net Debt to LTM Adjusted EBITDA was unchanged at 0.1x (Net Debt free excluding these real-estate leases). As of January 31, 2024, Quanex's LTM Adjusted EBITDA was $158.4 million and LTM Net Income, the most directly comparable GAAP measure, was $86.8 million. (See Non-GAAP Terminology Definitions and Disclaimers section, Net Debt Reconciliation table and Last Twelve Months Adjusted EBITDA Reconciliation table for additional information)

Outlook

Mr. Wilson commented, "As mentioned on our December call, we entered this year with a somewhat cautious outlook for the first half due to the ongoing macroeconomic challenges, but we remain optimistic that demand for our products will improve in the second half as consumer confidence is restored over time. Based on conversations with our customers, recent demand trends, and the latest macro data, we are now comfortable providing guidance for fiscal 2024. Overall, on a consolidated basis, we estimate we will generate net sales of approximately $1.1 billion, which we expect will yield approximately $145 million to $150 million in Adjusted EBITDA* in fiscal 2024. While the near-term outlook for our business remains somewhat cautious, our long-term view has not changed, and we believe the underlying fundamentals for the residential housing market remain positive."

*When Quanex provides expectations for Adjusted EBITDA on a forward-looking basis, a reconciliation of the differences between the non-GAAP expectations and corresponding GAAP measures is generally not available without unreasonable effort. Certain items required for such a reconciliation are outside of the Company's control and/or cannot be reasonably predicted or estimated, such as the provision for income taxes.

Conference Call and Webcast Information

The Company has also scheduled a conference call for Friday, March 8, 2024 at 11:00 a.m. ET (10:00 a.m. CT) to discuss the release. A link to the live audio webcast will be available on Quanex's website at http://www.quanex.com in the Investors section under Presentations & Events.

Participants can pre-register for the conference call using the following link: https://register.vevent.com/register/BI8100cd976cdb4a18aa0a5bcef75a89d8

Registered participants will receive an email containing conference call details for dial-in options. To avoid delays, it is recommended that participants dial into the conference call ten minutes ahead of the scheduled start time. A replay will be available for a limited time on the Company's website at http://www.quanex.com in the Investors section under Presentations & Events.

About Quanex

Quanex is a global manufacturer with core capabilities and broad applications across various end markets. The Company currently collaborates and partners with leading OEMs to provide innovative solutions in the window, door, vinyl fencing, solar, refrigeration, custom mixing and cabinetry markets. Looking ahead, Quanex plans to leverage its material science expertise and process engineering to expand into adjacent markets.

For more information contact Scott Zuehlke, Senior Vice President, Chief Financial Officer & Treasurer, at 713-877-5327 or scott.zuehlke@quanex.com.

Non-GAAP Terminology Definitions and Disclaimers

Adjusted Net Income (defined as net income further adjusted to exclude purchase price accounting inventory step-ups, transaction costs, certain severance charges, gain/loss on the sale of certain fixed assets, restructuring charges, asset impairment charges, other net adjustments related to foreign currency transaction gain/loss and effective tax rates reflecting impacts of adjustments on a with and without basis) and Adjusted EPS are non-GAAP financial measures that Quanex believes provide a consistent basis for comparison between periods and more accurately reflects operational performance, as they are not influenced by certain income or expense items not affecting ongoing operations. EBITDA (defined as net income or loss before interest, taxes, depreciation and amortization and other, net) and Adjusted EBITDA (defined as EBITDA further adjusted to exclude purchase price accounting inventory step-ups, transaction costs, certain severance charges, gain/loss on the sale of certain fixed assets, restructuring charges and asset impairment charges) are non-GAAP financial measures that the Company uses to measure operational performance and assist with financial decision-making. Net Debt is defined as total debt (outstanding balance on the revolving credit facility plus financial lease obligations) less cash and cash equivalents. The leverage ratio of Net Debt to LTM Adjusted EBITDA is a financial measure that the Company believes is useful to investors and financial analysts in evaluating Quanex's leverage. In addition, with certain limited adjustments, this leverage ratio is the basis for a key covenant in the Company's credit agreement.

Free Cash Flow is a non-GAAP measure calculated using cash provided by operating activities less capital expenditures. Quanex uses the Free Cash Flow metric to measure operational and cash management performance and assist with financial decision-making. Free Cash Flow is measured before application of certain contractual commitments (including capital lease obligations), and accordingly is not a true measure of the Company's residual cash flow available for discretionary expenditures. Quanex believes Free Cash Flow is useful to investors in understanding and evaluating the Company's financial and cash management performance.

Quanex believes that the presented non-GAAP measures provide a consistent basis for comparison between periods and will assist investors in understanding the Company's financial performance when comparing results to other investment opportunities. The presented non-GAAP measures may not be the same as those used by other companies. Quanex does not intend for this information to be considered in isolation or as a substitute for other measures prepared in accordance with U.S. GAAP.

Forward Looking Statements

Statements that use the words "estimated," "expect," "could," "should," "believe," "will," "might," or similar words reflecting future expectations or beliefs are forward-looking statements. The forward-looking statements include, but are not limited to, the following: impacts from public health issues (including pandemics, such as the recent COVID-19 pandemic) on the economy and the demand for Quanex's products, the Company's future operating results, future financial condition, future uses of cash and other expenditures, expenses and tax rates, expectations relating to Quanex's industry, and the Company's future growth, including any guidance discussed in this press release. The statements and guidance set forth in this release are based on current expectations. Actual results or events may differ materially from this release. For a complete discussion of factors that may affect Quanex's future performance, please refer to the Company's Annual Report on Form 10-K for the fiscal year ended October 31, 2022, and the Company's Quarterly Reports on Form 10-Q under the sections entitled "Cautionary Note Regarding Forward-Looking Statements" and "Risk Factors". Any forward-looking statements in this press release are made as of the date hereof, and Quanex undertakes no obligation to update or revise any forward-looking statements to reflect new information or events.

CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(In thousands, except per share data)
(Unaudited)
Three Months Ended January 31,
2024 2023
Net sales $239,155 $261,916
Cost of sales 187,723 210,149
Selling, general and administrative 32,363 36,744
Depreciation and amortization 11,152 10,620
Operating income 7,917 4,403
Interest expense (1,068) (2,259)
Other, net 1,042 218
Income before income taxes 7,891 2,362
Income tax expense (1,642) (453)
Net income $6,249 $1,909
Earnings per common share, basic $0.19 $0.06
Earnings per common share, diluted $0.19 $0.06
Weighted average common shares outstanding:
Basic 32,825 32,951
Diluted 33,043 33,137
Cash dividends per share $0.08 $0.08


QUANEX BUILDING PRODUCTS CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands)
(Unaudited)
January 31, 2024 October 31, 2023
ASSETS
Current assets:
Cash and cash equivalents $44,422 $58,474
Accounts receivable, net 80,063 97,311
Inventories 107,478 97,959
Income taxes receivable 7,642 8,298
Prepaid and other current assets 13,390 11,558
Total current assets 252,995 273,600
Property, plant and equipment, net 253,681 250,664
Operating lease right-of-use assets 46,370 46,620
Goodwill 185,439 182,956
Intangible assets, net 72,008 74,115
Other assets 2,927 3,188
Total assets $813,420 $831,143
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Accounts payable $55,106 $74,371
Accrued liabilities 46,478 50,319
Income taxes payable - 384
Current maturities of long-term debt 2,500 2,365
Current operating lease liabilities 7,370 7,224
Total current liabilities 111,454 134,663
Long-term debt 61,594 66,435
Noncurrent operating lease liabilities 40,084 40,361
Deferred income taxes 30,737 29,133
Other liabilities 14,522 14,997
Total liabilities 258,391 285,589
Stockholders' equity:
Common stock 371 372
Additional paid-in-capital 248,715 251,576
Retained earnings 412,922 409,318
Accumulated other comprehensive loss (32,060) (38,141)
Treasury stock at cost (74,919) (77,571)
Total stockholders' equity 555,029 545,554
Total liabilities and stockholders' equity $813,420 $831,143
QUANEX BUILDING PRODUCTS CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOW
(In thousands)
(Unaudited)
Three Months Ended January 31,
2024 2023
Operating activities:
Net income$6,249 $1,909
Adjustments to reconcile net income to cash provided by operating activities:
Depreciation and amortization 11,152 10,620
Stock-based compensation 583 679
Deferred income tax 1,136 179
Other, net 1,790 1,509
Changes in assets and liabilities:
Decrease in accounts receivable 18,147 20,502
(Increase) decrease in inventory (8,756) 645
Increase in other current assets (1,680) (1,431)
Decrease in accounts payable (19,044) (21,379)
Decrease in accrued liabilities (7,181) (12,686)
Increase in income taxes payable 264 536
Increase in deferred pension benefits - 7
Increase in other long-term liabilities 852 1,461
Other, net 342 584
Cash provided by operating activities 3,854 3,135
Investing activities:
Business acquisition - (92,000)
Capital expenditures (9,580) (7,582)
Proceeds from disposition of capital assets 31 98
Cash used for investing activities (9,549) (99,484)
Financing activities:
Borrowings under credit facilities - 102,000
Repayments of credit facility borrowings (5,000) (15,000)
Repayments of other long-term debt (679) (579)
Common stock dividends paid (2,645) (2,661)
Issuance of common stock 400 99
Payroll tax paid to settle shares forfeited upon vesting of stock (1,193) (545)
Cash (used for) provided by financing activities (9,117) 83,314
Effect of exchange rate changes on cash and cash equivalents 760 997
Decrease in cash and cash equivalents (14,052) (12,038)
Cash and cash equivalents at beginning of period 58,474 55,093
Cash and cash equivalents at end of period$44,422 $43,055


QUANEX BUILDING PRODUCTS CORPORATION
FREE CASH FLOW AND NET DEBT RECONCILIATION
(In thousands)
(Unaudited)
The following table reconciles the Company's calculation of Free Cash Flow, a non-GAAP measure, to its most directly comparable GAAP measure. The Company defines Free Cash Flow as cash provided by operating activities less capital expenditures.
Three Months Ended January 31,
2024 2023
Cash provided by operating activities $3,854 $3,135
Capital expenditures (9,580) (7,582)
Free Cash Flow ($5,726) ($4,447)
The following table reconciles the Company's Net Debt which is defined as total debt principal of the Company plus finance lease obligations minus cash.
As of January 31,
2024 2023
Revolving credit facility $10,000 $100,000
Finance lease obligations(1) 55,211 55,122
Total debt(2) 65,211 155,122
Less: Cash and cash equivalents 44,422 43,055
Net Debt $20,789 $112,067
(1) Includes $51.7 million and $53.2 million in real estate lease liabilities considered finance leases under U.S. GAAP as of January 31, 2024 and January 31, 2023, respectively.
(2) Excludes outstanding letters of credit.


QUANEX BUILDING PRODUCTS CORPORATION
NON-GAAP FINANCIAL MEASURE DISCLOSURE
LAST TWELVE MONTHS ADJUSTED EBITDA RECONCILIATION
(In thousands, except per share data)
(Unaudited)
Reconciliation of Last Twelve Months Adjusted EBITDA Three Months Ended
January 31, 2024
Three Months Ended
October 31, 2023
Three Months Ended
July 31, 2023
Three Months Ended
April 30, 2023
Total
Reconciliation Reconciliation Reconciliation Reconciliation Reconciliation
Net income as reported $6,249 $27,382 $31,698 $21,512 $86,841
Income tax expense 1,642 4,442 4,099 5,551 15,734
Other, net (1,042) 6,110 (402) 29 4,695
Interest expense 1,068 1,565 2,068 2,244 6,945
Depreciation and amortization 11,152 11,194 10,596 10,456 43,398
EBITDA 19,069 50,693 48,059 39,792 157,613
Cost of sales(1) - (35) - 48 13
Selling, general and administrative(1),(2) 205 109 395 63 772
Adjusted EBITDA $19,274 $50,767 $48,454 $39,903 $158,398
(1) Loss on damage to manufacturing facilities caused by weather.
(2) Transaction and advisory fees.
QUANEX BUILDING PRODUCTS CORPORATION
NON-GAAP FINANCIAL MEASURE DISCLOSURE
(In thousands, except per share data)
(Unaudited)
Reconciliation of Adjusted Net Income and Adjusted EPSThree Months Ended
January 31, 2024
Three Months Ended
January 31, 2023
Net
Income
Diluted
EPS
Net
Income
Diluted
EPS
Net income as reported $6,249 $0.19 $1,909 $0.06
Net income reconciling items from below (435) $(0.01) 4,154 $0.12
Adjusted net income and adjusted EPS $5,814 $0.18 $6,063 $0.18
Reconciliation of Adjusted EBITDA Three Months Ended
January 31, 2024
Three Months Ended
January 31, 2023
Reconciliation Reconciliation
Net income as reported $6,249 $1,909
Income tax expense 1,642 453
Other, net (1,042) (218)
Interest expense 1,068 2,259
Depreciation and amortization 11,152 10,620
EBITDA 19,069 15,023
EBITDA reconciling items from below 205 5,448
Adjusted EBITDA $19,274 $20,471
Reconciling Items Three Months Ended
January 31, 2024
Three Months Ended
January 31, 2023
Income
Statement
Reconciling
Items
Income
Statement
Reconciling
Items
Net sales $239,155 $- $261,916 $-
Cost of sales 187,723 - 210,149 -
Selling, general and administrative 32,363 (205)(1) 36,744 (5,448)(1)
EBITDA 19,069 205 15,023 5,448
Depreciation and amortization 11,152 - 10,620 -
Operating income 7,917 205 4,403 5,448
Interest expense (1,068) - (2,259) -
Other, net 1,042 (755)(2) 218 (42)(2)
Income before income taxes 7,891 (550) 2,362 5,406
Income tax expense (1,642) 115 (3) (453) (1,252)(3)
Net income $6,249 $(435) $1,909 $4,154
Diluted earnings per share $0.19 $0.06
(1) Transaction and advisory fees.
(2) Pension settlement refund and foreign currency transaction losses (gains).
(3) Tax impact of net income reconciling items.
QUANEX BUILDING PRODUCTS CORPORATION
SELECTED SEGMENT DATA
(In thousands)
(Unaudited)
This table provides gross margin, operating income (loss), EBITDA, and Adjusted EBITDA by reportable segment. Non-operating expense and income tax expense are not allocated to the reportable segments.
NA Fenestration EU Fenestration NA Cabinet
Components
Unallocated
Corp & Other
Total
Three months ended January 31, 2024
Net sales $147,995 $49,437 $43,137 $(1,414) $239,155
Cost of sales 118,368 31,703 38,743 (1,091) 187,723
Gross Margin 29,627 17,734 4,394 (323) 51,432
Gross Margin % 20.0% 35.9% 10.2% 21.5%
Selling, general and administrative(1) 15,910 7,745 5,126 3,582 32,363
Depreciation and amortization 5,475 2,558 3,065 54 11,152
Operating income (loss) 8,242 7,431 (3,797) (3,959) 7,917
Depreciation and amortization 5,475 2,558 3,065 54 11,152
EBITDA 13,717 9,989 (732) (3,905) 19,069
Transaction and advisory fees - - - 205 205
Adjusted EBITDA $13,717 $9,989 $(732) $(3,700) $19,274
Adjusted EBITDA Margin % 9.3% 20.2% -1.7% 8.1%
Three months ended January 31, 2023
Net sales $152,980 $54,952 $54,674 $(690) $261,916
Cost of sales 124,717 37,703 48,056 (327) 210,149
Gross Margin 28,263 17,249 6,618 (363) 51,767
Gross Margin % 18.5% 31.4% 12.1% 19.8%
Selling, general and administrative(1) 13,295 7,505 4,873 11,071 36,744
Depreciation and amortization 5,245 2,348 2,934 93 10,620
Operating income (loss) 9,723 7,396 (1,189) (11,527) 4,403
Depreciation and amortization 5,245 2,348 2,934 93 10,620
EBITDA 14,968 9,744 1,745 (11,434) 15,023
Transaction and advisory fees - - - 5,448 5,448
Adjusted EBITDA $14,968 $9,744 $1,745 $(5,986) $20,471
Adjusted EBITDA Margin % 9.8% 17.7% 3.2% 7.8%
(1) Includes stock-based compensation expense of $2.6 million and $4.8 million as of January 31, 2024 and January 31, 2023, respectively.
QUANEX BUILDING PRODUCTS CORPORATION
SALES ANALYSIS
(In thousands)
(Unaudited)
Three Months Ended October 31,
2024 2023
NA Fenestration:
United States - fenestration$111,634 $120,767
International - fenestration 6,144 5,127
United States - non-fenestration 25,791 23,066
International - non-fenestration 4,426 4,020
$147,995 $152,980
EU Fenestration:(1)
International - fenestration$41,751 $42,354
International - non-fenestration 7,686 12,598
$49,437 $54,952
NA Cabinet Components:
United States - fenestration$3,675 $3,908
United States - non-fenestration 39,179 50,049
International - non-fenestration 283 717
$43,137 $54,674
Unallocated Corporate & Other:
Eliminations$(1,414) $(690)
$(1,414) $(690)
Net Sales$239,155 $261,916
(1) Reflects an increase of $1.0 million in revenue associated with foreign currency exchange rate impacts for the three months ended January 31, 2024.

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2024 GlobeNewswire (Europe)
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.